Skip to main content
PMC home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1999 Jun;52(3):151–157. doi: 10.1136/mp.52.3.151

Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours.

D S Sanders 1, K Blessing 1, G A Hassan 1, R Bruton 1, J R Marsden 1, J Jankowski 1
PMCID: PMC395690  PMID: 10621837

Abstract

AIMS: Compelling evidence from cell culture studies implicates cadherins in the neoplastic progression of melanocytic tumours but few reports describe the expression of cadherins and the related transmembrane proteins, catenins, in a full range of benign and malignant excised melanocytic tumours. METHODS: Using immunohistochemistry and western blotting after tissue fractionation, the pattern of expression of cadherins/catenins was studied in a range of surgically excised melanocytic tumours, from dysplastic naevi to stage III cutaneous metastatic malignant melanoma. RESULTS: Appropriate membranous expression of E-cadherins and P-cadherins is seen in dysplastic naevocytes with an epithelioid phenotype and is largely maintained with malignant transformation to radial growth phase melanoma and primary vertical growth phase malignant melanoma. Loss of membranous E-cadherin is seen in a small number of vertical growth phase melanomas only when metastasis has occurred. However, there is a concomitant dramatic loss of membranous P-cadherin expression in all melanomas at the same stage. A minority of metastatic melanomas show de novo membranous N-cadherin expression in comparison with dysplastic naevi and primary melanoma. Membranous expression of the desmosomal cadherin, desmoglein, was not seen in any tumour studied. Frequently, beta catenin is aberrantly produced in the cytoplasm of cells in dysplastic naevi and metastatic malignant melanoma, with an implied compromise to adhesive function. Furthermore, membranous gamma catenin expression was not seen in any of the 70 melanocytic tumours studied, implying obligatory transmembrane binding of cadherins to beta catenin for maintenance of adhesive function. CONCLUSIONS: The most important alterations in membranous cadherin and catenin expression are seen late in the biological progression of melanocytic tumours at the stage of "in transit" or regional lymph node metastasis, with implications for tumour growth, invasion, and dissemination.

Full Text

The Full Text of this article is available as a PDF (365.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey T., Biddlestone L., Shepherd N., Barr H., Warner P., Jankowski J. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am J Pathol. 1998 Jan;152(1):135–144. [PMC free article] [PubMed] [Google Scholar]
  2. Black W. C., Hunt W. C. Histologic correlations with the clinical diagnosis of dysplastic nevus. Am J Surg Pathol. 1990 Jan;14(1):44–52. doi: 10.1097/00000478-199001000-00005. [DOI] [PubMed] [Google Scholar]
  3. Clark W. H., Jr, Elder D. E., Guerry D., 4th, Epstein M. N., Greene M. H., Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol. 1984 Dec;15(12):1147–1165. doi: 10.1016/s0046-8177(84)80310-x. [DOI] [PubMed] [Google Scholar]
  4. Cowley G. P., Smith M. E. Cadherin expression in melanocytic naevi and malignant melanomas. J Pathol. 1996 Jun;179(2):183–187. doi: 10.1002/(SICI)1096-9896(199606)179:2<183::AID-PATH554>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  5. Danen E. H., de Vries T. J., Morandini R., Ghanem G. G., Ruiter D. J., van Muijen G. N. E-cadherin expression in human melanoma. Melanoma Res. 1996 Apr;6(2):127–131. doi: 10.1097/00008390-199604000-00007. [DOI] [PubMed] [Google Scholar]
  6. Denton K. J., Stretch J. R., Gatter K. C., Harris A. L. A study of adhesion molecules as markers of progression in malignant melanoma. J Pathol. 1992 Jun;167(2):187–191. doi: 10.1002/path.1711670205. [DOI] [PubMed] [Google Scholar]
  7. Dorudi S., Sheffield J. P., Poulsom R., Northover J. M., Hart I. R. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol. 1993 Apr;142(4):981–986. [PMC free article] [PubMed] [Google Scholar]
  8. Frixen U. H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., Löchner D., Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 1991 Apr;113(1):173–185. doi: 10.1083/jcb.113.1.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Guerry D., 4th, Synnestvedt M., Elder D. E., Schultz D. Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J Invest Dermatol. 1993 Mar;100(3):342S–345S. doi: 10.1111/1523-1747.ep12470248. [DOI] [PubMed] [Google Scholar]
  10. Johnson J. P., Stade B. G., Holzmann B., Schwäble W., Riethmüller G. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci U S A. 1989 Jan;86(2):641–644. doi: 10.1073/pnas.86.2.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lewis J. E., Wahl J. K., 3rd, Sass K. M., Jensen P. J., Johnson K. R., Wheelock M. J. Cross-talk between adherens junctions and desmosomes depends on plakoglobin. J Cell Biol. 1997 Feb 24;136(4):919–934. doi: 10.1083/jcb.136.4.919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Maeurer M. J., Storkus W. J., Kirkwood J. M., Lotze M. T. New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines. Melanoma Res. 1996 Feb;6(1):11–24. doi: 10.1097/00008390-199602000-00003. [DOI] [PubMed] [Google Scholar]
  13. Matsuyoshi N., Tanaka T., Toda K., Imamura S. Identification of novel cadherins expressed in human melanoma cells. J Invest Dermatol. 1997 Jun;108(6):908–913. doi: 10.1111/1523-1747.ep12292703. [DOI] [PubMed] [Google Scholar]
  14. Mazur M. T., Katzenstein A. L. Metastatic melanoma: the spectrum of ultrastructural morphology. Ultrastruct Pathol. 1980 Jul-Sep;1(3):337–356. doi: 10.3109/01913128009141436. [DOI] [PubMed] [Google Scholar]
  15. Moll R., Mitze M., Frixen U. H., Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol. 1993 Dec;143(6):1731–1742. [PMC free article] [PubMed] [Google Scholar]
  16. Natali P., Nicotra M. R., Cavaliere R., Bigotti A., Romano G., Temponi M., Ferrone S. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res. 1990 Feb 15;50(4):1271–1278. [PubMed] [Google Scholar]
  17. Nesbit M., Herlyn M. Adhesion receptors in human melanoma progression. Invasion Metastasis. 1994;14(1-6):131–146. [PubMed] [Google Scholar]
  18. Robbins P. F., El-Gamil M., Li Y. F., Kawakami Y., Loftus D., Appella E., Rosenberg S. A. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med. 1996 Mar 1;183(3):1185–1192. doi: 10.1084/jem.183.3.1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sanders D. S., Evans A. T., Allen C. A., Bryant F. J., Johnson G. D., Hopkins J., Stocks S. C., Marsden J. R., Kerr M. A. Classification of CEA-related positivity in primary and metastatic malignant melanoma. J Pathol. 1994 Apr;172(4):343–348. doi: 10.1002/path.1711720409. [DOI] [PubMed] [Google Scholar]
  20. Sandig M., Voura E. B., Kalnins V. I., Siu C. H. Role of cadherins in the transendothelial migration of melanoma cells in culture. Cell Motil Cytoskeleton. 1997;38(4):351–364. doi: 10.1002/(SICI)1097-0169(1997)38:4<351::AID-CM5>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  21. Schipper J. H., Frixen U. H., Behrens J., Unger A., Jahnke K., Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 1991 Dec 1;51(23 Pt 1):6328–6337. [PubMed] [Google Scholar]
  22. Seline P. C., Norris D. A., Horikawa T., Fujita M., Middleton M. H., Morelli J. G. Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation. J Invest Dermatol. 1996 Jun;106(6):1320–1324. doi: 10.1111/1523-1747.ep12349048. [DOI] [PubMed] [Google Scholar]
  23. Shi S. R., Key M. E., Kalra K. L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991 Jun;39(6):741–748. doi: 10.1177/39.6.1709656. [DOI] [PubMed] [Google Scholar]
  24. Siitonen S. M., Kononen J. T., Helin H. J., Rantala I. S., Holli K. A., Isola J. J. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol. 1996 Apr;105(4):394–402. doi: 10.1093/ajcp/105.4.394. [DOI] [PubMed] [Google Scholar]
  25. Silye R., Karayiannakis A. J., Syrigos K. N., Poole S., van Noorden S., Batchelor W., Regele H., Sega W., Boesmueller H., Krausz T. E-cadherin/catenin complex in benign and malignant melanocytic lesions. J Pathol. 1998 Dec;186(4):350–355. doi: 10.1002/(SICI)1096-9896(199812)186:4<350::AID-PATH181>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  26. Steinberg M. S., Takeichi M. Experimental specification of cell sorting, tissue spreading, and specific spatial patterning by quantitative differences in cadherin expression. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):206–209. doi: 10.1073/pnas.91.1.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991 Mar 22;251(5000):1451–1455. doi: 10.1126/science.2006419. [DOI] [PubMed] [Google Scholar]
  28. Tang A., Eller M. S., Hara M., Yaar M., Hirohashi S., Gilchrest B. A. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci. 1994 Apr;107(Pt 4):983–992. doi: 10.1242/jcs.107.4.983. [DOI] [PubMed] [Google Scholar]
  29. Wang R. F., Rosenberg S. A. Human tumor antigens recognized by T lymphocytes: implications for cancer therapy. J Leukoc Biol. 1996 Sep;60(3):296–309. doi: 10.1002/jlb.60.3.296. [DOI] [PubMed] [Google Scholar]
  30. Yoshimura M., Ihara Y., Matsuzawa Y., Taniguchi N. Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem. 1996 Jun 7;271(23):13811–13815. doi: 10.1074/jbc.271.23.13811. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES